BDBM323172 N-[(S)-1-[(S)-2-(3-Butoxy-3-phenylazetidin-1-yl)-1-(4-methoxybenzyl)-2-oxoethylcarbamoyl]-2-(1H-imidazol-4-yl)ethyl]benzamide::US9630949, 1::US9630949, 3

SMILES CCCCOC1(c2ccccc2)CN(C(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)c2ccccc2)C1

InChI Key InChIKey=XFIFHRNMGSCAGO-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 323172   

TargetMelanocyte-stimulating hormone receptor(Human)
Galderma Research & Development

US Patent
LigandChemical structure of BindingDB Monomer ID 323172BDBM323172(US9630949, 1 | US9630949, 3 | N-[(S)-1-[(S)-2-(3-B...)
Affinity DataEC50:  60nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2019
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Galderma Research & Development

US Patent
LigandChemical structure of BindingDB Monomer ID 323172BDBM323172(US9630949, 1 | US9630949, 3 | N-[(S)-1-[(S)-2-(3-B...)
Affinity DataEC50:  500nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2019
Entry Details
US Patent

TargetMelanocortin receptor 4(Human)
Galderma Research & Development

US Patent
LigandChemical structure of BindingDB Monomer ID 323172BDBM323172(US9630949, 1 | US9630949, 3 | N-[(S)-1-[(S)-2-(3-B...)
Affinity DataEC50:  4.00E+3nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2019
Entry Details
US Patent